Advanced search
Publication Cover
International Journal of Neuroscience Volume 121, 2011 - Issue 5
Submit an article Journal homepage
254
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson's Disease

Robert A. HauserDepartments of Neurology, Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida, USACorrespondence[email protected]
,
Heinz ReichmannDepartment of Neurology, University of Technology, Dresden, Germany
,
Mark LewDepartment of Neurology, Keck/USC School of Medicine, Los Angeles, California, USA
,
Afsaneh AsgharianGlaxoSmithKline, Research Triangle Park, North Carolina, USA
,
Clare MakumiGlaxoSmithKline, Research Triangle Park, North Carolina, USA
&
Kenneth J. ShulmanGlaxoSmithKline, Research Triangle Park, North Carolina, USA
Pages 246-253 | Received 16 Sep 2010, Published online: 19 Jan 2011

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Roberto Ceravolo, Carlo Rossi, Eleonora Del Prete & Ubaldo Bonuccelli. (2016) A review of adverse events linked to dopamine agonists in the treatment of Parkinson’s disease. Expert Opinion on Drug Safety 15:2, pages 181-198.
Read now
Clare W. Makumi, Afsaneh Asgharian, Jeffrey Ellis, Soraya Shaikh, Teri Jimenez & Susan VanMeter. (2016) Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson's disease. International Journal of Neuroscience 126:1, pages 30-38.
Read now
Zhenxin Zhang, Jian Wang, Xiaoying Zhang, Shengdi Chen, Zhenfu Wang, Baorong Zhang, Chunfeng Liu, Qiumin Qu, Yan Cheng, Rongxuan Zhu, Jie Li, Jingqiu Hu & Meng Cai. (2015) An open-label extension study to evaluate the safety of ropinirole prolonged release in Chinese patients with advanced Parkinson’s disease. Current Medical Research and Opinion 31:4, pages 723-730.
Read now
Fabio Blandini & Marie-Therese Armentero. (2014) Dopamine receptor agonists for Parkinson's disease. Expert Opinion on Investigational Drugs 23:3, pages 387-410.
Read now

Articles from other publishers (11)

Nicki Niemann, Andrew Billnitzer & Joseph Jankovic. (2021) Parkinson's disease and skin. Parkinsonism & Related Disorders 82, pages 61-76.
Crossref
Saman Fatima, Sarwar Beg, Mohammed Samim & Farhan J. Ahmad. (2019) Application of chemometric approach for development and validation of high performance liquid chromatography method for estimation of ropinirole hydrochloride. Journal of Separation Science 42:21, pages 3293-3301.
Crossref
Hazem A. Ghabbour, Abdulrahman Al-Majed, Obaid S. Alruqi & Gamal A. E. Mostafa. (2016) Crystal structure of N -(2-(2-oxoindolin-4-yl)ethyl)- N -propylpropan-1-aminium tetraphenylborate, C 40 H 45 BN 2 O . Zeitschrift für Kristallographie - New Crystal Structures 231:3, pages 921-923.
Crossref
Robert A. Hauser, C. Warren Olanow, Bruce Dzyngel, Thierry Bilbault, Holly Shill, Stuart Isaacson, Jordan Dubow & Albert Agro. (2016) Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease. Movement Disorders 31:9, pages 1366-1372.
Crossref
Ramon Lugo-Sanchez & Néstor Gálvez-Jiménez. 2016. Parkinson's Disease. Parkinson's Disease 280 286 .
. 2016. Parkinson's Disease. Parkinson's Disease 231 360 .
Ilona Csoti, Wolfgang H. Jost & Heinz Reichmann. (2015) Parkinson’s disease between internal medicine and neurology. Journal of Neural Transmission 123:1, pages 3-17.
Crossref
J. Fuster, S. Negro, A. Salama, A. Fernández-Carballido, P. Marcianes, L. Boeva & E. Barcia. (2015) HPLC-UV method development and validation for the quantification of ropinirole in new PLGA multiparticulate systems: Microspheres and nanoparticles. International Journal of Pharmaceutics 491:1-2, pages 310-317.
Crossref
Oliver Riedel, Jens Klotsche & Hans-Ulrich Wittchen. (2014) Motor impairment, depression, dementia: Which forms the impression of disease severity in Parkinson's disease?. Parkinsonism & Related Disorders 20:12, pages 1365-1370.
Crossref
Daniela Calandrella & Angelo Antonini. (2012) Pulsatile or continuous dopaminomimetic strategies in Parkinson's disease. Parkinsonism & Related Disorders 18, pages S120-S122.
Crossref
Lawrence ElmerRobert A Hauser. (2011) Strategies for Parkinson’s disease care: prevention and management of motor fluctuations. Neurodegenerative Disease Management 1:5, pages 415-430.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.